Skip to main content
Dr. Miltie  |  Clinical technology for care wherever it happens. Need funding? Explore Atlas by Dr. Miltie (opens in a new tab)
•Blog

March 2020 CMS Medicare Advantage and Part D Guidance (Archived)

Historical CMS guidance from March 2020 on Medicare Advantage and Part D emergency flexibilities, with current-policy cautions and official references.

Historical Medicare guidance (March 2020): This article reports emergency-era Medicare Advantage and Part D flexibilities, not current plan coverage, cost sharing, refill rules, or prior authorization requirements. The federal COVID-19 public health emergency ended May 11, 2023. See the original CMS announcement and current Medicare cost information.

On March 10, 2020, the Centers for Medicare & Medicaid Services (CMS) issued guidance describing emergency flexibilities and obligations for Medicare Advantage organizations and Part D sponsors during COVID-19.

Flexibilities

Medicare Advantage Plans (MA). In the memorandum issued, CMS outlined the flexibilities Medicare Advantage and Part D plans have to waive certain requirements. These flexibilities include:

  • Waiving cost-sharing for COVID-19 tests
  • Waiving cost-sharing for COVID-19 treatments in doctors’ offices or emergency rooms and services delivered via telehealth
  • Removing prior authorization requirements
  • Waiving prescription refill limits, relaxing restrictions on home or mail delivery of prescription drugs
  • Expanding access to certain telehealth services

Part D Sponsors. Part D sponsors may also take the following actions to ensure pharmacy access during a disaster or state of emergency resulting from COVID-19:

  • Relax “Refill-Too-Soon” Edits and Provide Maximum Extended Day Supply – Part D sponsors may relax their “refill-too-soon” edits if circumstances are reasonably expected to result in a disruption in access to drugs.
  • Reimburse Enrollees for Prescriptions Obtained from Out-of-Network Pharmacies – Part D sponsors must ensure enrollees have adequate access to covered Part D drugs dispensed at out-of-network pharmacies when those enrollees cannot reasonably be expected to obtain covered Part D drugs at a network pharmacy.
  • Home or Mail Delivery of Part D Drugs – In situations when a disaster or emergency makes it difficult for enrollees to get to a retail pharmacy, or enrollees are actually prohibited from going to a retail pharmacy (e.g., in a quarantine situation), Part D sponsors are permitted to voluntarily relax any plan-imposed policies that may discourage certain methods of delivery.
  • Prior Authorization for Part D Drugs – As is the case for Medicare Advantage organizations, consistent with flexibilities available to Part D sponsors absent a disaster or emergency, Part D sponsors may choose to waive prior authorization requirements at any time.

Special Requirements

Special requirements during a disaster or emergency related to Part A/B and supplemental Part C benefit access can be found at 42 CFR 422.100(m). A declaration by the state’s governor or protectorate is one of the triggering events for these special requirements. Under the regulation, special requirements are in effect until the end date identified in the state declaration or for 30 days, if no end date is identified in the declaration. To date, declarations have been made in at least 18 states.

These special requirements include:

  • Cover Medicare Parts A and B services and supplemental Part C plan benefits furnished at non-contracted facilities. Note: facilities that furnish covered A/B benefits must have participation agreements with Medicare.
  • Waive, in full, requirements for gatekeeper referrals where applicable.
  • Provide the same cost-sharing for the enrollee as if the service or benefit had been furnished at a plan-contracted facility.
  • Make changes that benefit the enrollee effective immediately without the 30-day notification requirement.

These useful resources provide greater detail:

Move from information to action

See how the N9+ can fit your organization.

Explore the remote physical exam platform or request a focused demonstration.